{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-080986","form_type":"8-K","ticker":"RGNX","cik":"0001590877","company_name":"REGENXBIO Inc.","filed_at":"2025-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.923531+00:00","generated_at":"2026-05-20T01:34:31.028473+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"confidence":"high","headline":"REGENXBIO stockholders elect four Class I directors, approve 2025 equity plan","bullets":["Four Class I directors elected: Fox (27.99M for), Glucksmann (29.26M), Simpson (32.80M), Zachary (29.18M) until 2028.","Ratified PricewaterhouseCoopers as independent auditor for FY2025: 41.17M for, 39,375 against.","Advisory approval of named executive officer compensation: 32.58M for, 1.76M against.","Advisory vote on frequency: 'Every 1 Year' received 33.15M votes; company will hold annual say-on-pay votes.","Approved 2025 Equity Incentive Plan: 27.40M for, 6.97M against."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-080986","json":"https://secwatch.observer/filing/0000950170-25-080986.json","markdown":"https://secwatch.observer/filing/0000950170-25-080986.md","text":"https://secwatch.observer/filing/0000950170-25-080986.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590877/000095017025080986/0000950170-25-080986-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590877/000095017025080986/rgnx-20250530.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T01:34:31.028473+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}